^( ) – Uncertainty (1σ) is given in concise form in parentheses after the corresponding last digits.
^# – Atomic mass marked #: value and uncertainty derived not from purely experimental data, but at least partly from trends from the Mass Surface (TMS).
^Bold italics symbol as daughter – Daughter product is nearly stable.
^Bold symbol as daughter – Daughter product is stable.
^( ) spin value – Indicates spin with weak assignment arguments.
^# – Values marked # are not purely derived from experimental data, but at least partly from trends of neighboring nuclides (TNN).
Bromine-75
Bromine-75 has a half-life of 97 minutes.[13] This isotope undergoes β+ decay rather than electron capture about 76% of the time,[6] so it was used for diagnosis and positron emission tomography (PET) in the 1980s.[4] However, its decay product, selenium-75, produces secondary radioactivity with a longer half-life of 120.4 days.[6][4]
Bromine-76
Bromine-76 has a half-life of 16.2 hours.[13] While its decay is more energetic than 75Br and has lower yield of positrons (about 57% of decays),[6] bromine-76 has been preferred in PET applications since the 1980s because of its longer half-life and easier synthesis, and because its decay product, 76Se, is not radioactive.[5]
Bromine-77
Bromine-77 is the most stable radioisotope of bromine, with a half-life of 57 hours.[13] Although β+ decay is possible for this isotope, about 99.3% of decays are by electron capture.[9] Despite its complex emission spectrum, featuring strong gamma-ray emissions at 239, 297, 521, and 579 keV,[14]77Br was used in SPECT imaging in the 1970s.[15] However, except for longer-term tracing,[6] this is no longer considered practical due to the difficult collimator requirements and the proximity of the 521 keV line to the 511 keV annihilation radiation related to the β+ decay.[15] The Auger electrons emitted during decay are nevertheless well-suited for radiotherapy, and 77Br can possibly be paired with the imaging-suited 76Br (produced as an impurity in common synthesis routes) for this application.[4][15]
^ abcdCoenen, Heinz H.; Ermert, Johannes (January 2021). "Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18". Nuclear Medicine and Biology. 92: 241–269. doi:10.1016/j.nucmedbio.2020.07.003. PMID32900582.
^ abWelch, Michael J.; Mcelvany, Karen D. (1 October 1983). "Radionuclides of Bromine for Use in Biomedical Studies". Ract. 34 (1–2): 41–46. doi:10.1524/ract.1983.34.12.41.
^ abcdefgLambert, F.; Slegers, G.; Hermanne, α.; Mertens, J. (1 June 1994). "Production and Purification of 77 Br Suitable for Labeling Monoclonal Antibodies Used in Tumor Imaging". Ract. 65 (4): 223–226. doi:10.1524/ract.1994.65.4.223.
^Wang, Meng; Huang, W.J.; Kondev, F.G.; Audi, G.; Naimi, S. (2021). "The AME 2020 atomic mass evaluation (II). Tables, graphs and references*". Chinese Physics C. 45 (3): 030003. doi:10.1088/1674-1137/abddaf.
^ abJaries, A.; Stryjczyk, M.; Kankainen, A.; Ayoubi, L. Al; Beliuskina, O.; Canete, L.; de Groote, R. P.; Delafosse, C.; Delahaye, P.; Eronen, T.; Flayol, M.; Ge, Z.; Geldhof, S.; Gins, W.; Hukkanen, M.; Imgram, P.; Kahl, D.; Kostensalo, J.; Kujanpää, S.; Kumar, D.; Moore, I. D.; Mougeot, M.; Nesterenko, D. A.; Nikas, S.; Patel, D.; Penttilä, H.; Pitman-Weymouth, D.; Pohjalainen, I.; Raggio, A.; Ramalho, M.; Reponen, M.; Rinta-Antila, S.; de Roubin, A.; Ruotsalainen, J.; Srivastava, P. C.; Suhonen, J.; Vilen, M.; Virtanen, V.; Zadvornaya, A. "Physical Review C - Accepted Paper: Isomeric states of fission fragments explored via Penning trap mass spectrometry at IGISOL". journals.aps.org. arXiv:2403.04710.
^ abShimizu, Y.; Kubo, T.; Sumikama, T.; Fukuda, N.; Takeda, H.; Suzuki, H.; Ahn, D. S.; Inabe, N.; Kusaka, K.; Ohtake, M.; Yanagisawa, Y.; Yoshida, K.; Ichikawa, Y.; Isobe, T.; Otsu, H.; Sato, H.; Sonoda, T.; Murai, D.; Iwasa, N.; Imai, N.; Hirayama, Y.; Jeong, S. C.; Kimura, S.; Miyatake, H.; Mukai, M.; Kim, D. G.; Kim, E.; Yagi, A. (8 April 2024). "Production of new neutron-rich isotopes near the N = 60 isotones Ge 92 and As 93 by in-flight fission of a 345 MeV/nucleon U 238 beam". Physical Review C. 109 (4): 044313. doi:10.1103/PhysRevC.109.044313.
^ abcAmjed, N.; Kaleem, N.; Wajid, A.M.; Naz, A.; Ahmad, I. (January 2024). "Evaluation of the cross section data for the low and medium energy cyclotron production of 77Br radionuclide". Radiation Physics and Chemistry. 214: 111286. doi:10.1016/j.radphyschem.2023.111286.
